BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37656169)

  • 1. Examining the association of clinician characteristics with perceived changes in cervical cancer screening and colposcopy practice during the COVID-19 pandemic: a mixed methods assessment.
    Fuzzell L; Brownstein NC; Fontenot HB; Lake PW; Michel A; Whitmer A; Rossi SL; McIntyre M; Vadaparampil ST; Perkins RB
    Elife; 2023 Sep; 12():. PubMed ID: 37656169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining the perceived impact of the COVID-19 pandemic on cervical cancer screening practices among clinicians practicing in Federally Qualified Health Centers: A mixed methods study.
    Fuzzell L; Lake P; Brownstein NC; Fontenot HB; Whitmer A; Michel A; McIntyre M; Rossi SL; Kajtezovic S; Vadaparampil ST; Perkins R
    Elife; 2023 Sep; 12():. PubMed ID: 37664989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pan-Canadian survey on the impact of the COVID-19 pandemic on cervical cancer screening and management: cross-sectional survey of healthcare professionals.
    El-Zein M; Ali R; Farah E; Botting-Provost S; Franco EL;
    Elife; 2023 Jun; 12():. PubMed ID: 37377399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cross-sectional survey examining clinician characteristics, practices, and attitudes associated with adoption of the 2019 American Society for Colposcopy and Cervical Pathology risk-based management consensus guidelines.
    Vadaparampil ST; Fuzzell LN; Brownstein NC; Fontenot HB; Lake P; Michel A; McIntyre M; Whitmer A; Perkins RB
    Cancer; 2023 Sep; 129(17):2671-2684. PubMed ID: 37221653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of the COVID-19 pandemic on the Ontario Cervical Screening Program, colposcopy and treatment services in Ontario, Canada: a population-based study.
    Meggetto O; Jembere N; Gao J; Walker MJ; Rey M; Rabeneck L; Murphy KJ; Kupets R;
    BJOG; 2021 Aug; 128(9):1503-1510. PubMed ID: 33982870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical Colposcopy: Indications and Risk Assessment.
    Burness JV; Schroeder JM; Warren JB
    Am Fam Physician; 2020 Jul; 102(1):39-48. PubMed ID: 32603071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of COVID-19-related care disruptions on cervical cancer screening in the United States.
    Burger EA; Jansen EE; Killen J; Kok IM; Smith MA; Sy S; Dunnewind N; G Campos N; Haas JS; Kobrin S; Kamineni A; Canfell K; Kim JJ
    J Med Screen; 2021 Jun; 28(2):213-216. PubMed ID: 33730899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of COVID-19 Pandemic on Screening Programs for Cervical Cancer Prevention Across Europe.
    Carcopino X; Cruickshank M; Leeson S; Redman C; Nieminen P
    J Low Genit Tract Dis; 2022 Jul; 26(3):219-222. PubMed ID: 35533257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring the activities of Italian colposcopy clinics before and during the COVID-19 pandemic.
    Delli Carpini G; Giorgi Rossi P; Giannella L; Di Giuseppe J; Clemente N; Sopracordevole F; Barbero M; Bogani G; De Vincenzo R; Origoni M; Cantatore F; Gardella B; Dominoni M; Monti E; Liverani CA; Viscardi A; Pagan A; Amadori A; Alessi C; Andolfatto M; Cattani P; Pieralli A; Stevenazzi G; Ciavattini A
    J Gynecol Oncol; 2023 Jan; 34(1):e7. PubMed ID: 36245226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Use of the Colposcopically Directed Punch Biopsy in Clinical Practice: A Survey of British Society of Colposcopy and Cervical Pathology (BSCCP)-Accredited Colposcopists.
    Myriokefalitaki E; Redman CW; Potdar N; Pearmain P; Moss EL
    J Low Genit Tract Dis; 2016 Jul; 20(3):234-8. PubMed ID: 27243143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancer screening in Poland in current SARS-CoV-2 pandemic: Interim guidelines of the Polish Society of Gynecologists and Obstetricians and the Polish Society of Colposcopy and Cervical Pathophysiology - a summary January 2021.
    Jach R; Mazurec M; Trzeszcz M; Zimmer M; Kedzia W; Wolski H
    Ginekol Pol; 2021; 92(2):165-173. PubMed ID: 33751524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 and inequities in colorectal and cervical cancer screening and diagnosis in Washington State.
    Amram O; Amiri S; Robison J; Pflugeisen CM; Monsivais P
    Cancer Med; 2022 Aug; 11(15):2990-2998. PubMed ID: 35304835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
    Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
    Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of COVID-19 on the cervical screening programme within a Northern Irish Health and Social care trust.
    McMullan JC; Rainey L; Morgan D; Johnston L
    Ulster Med J; 2023 May; 92(2):84-88. PubMed ID: 37649920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical pap smears and pandemics: The effect of COVID-19 on screening uptake & opportunities to improve.
    Masson H
    Womens Health (Lond); 2021; 17():17455065211017070. PubMed ID: 34032158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disclosing the results of the invasive cervical cancer review to patients: a survey of lead colposcopists across England.
    Sherman SM; Nailer E; Pearmain P; Todd RW; Redman CW
    Cytopathology; 2016 Aug; 27(4):237-41. PubMed ID: 26566859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Welsh cervical screening programme learning as a consequence of the coronavirus pandemic.
    Leeson S; Evered A; Powell G; Lilly K; Singh N; Hillier S; Dunk L
    Cytopathology; 2022 May; 33(3):350-356. PubMed ID: 34935223
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.